SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002383
Filing Date
2015-11-06
Accepted
2015-11-06 08:01:35
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amag-20150930x10q.htm 10-Q 2632994
2 EX-10.1 amag-20150930ex10164a54a.htm EX-10.1 74359
3 EX-31.1 amag-20150930ex311a250cc.htm EX-31.1 18384
4 EX-31.2 amag-20150930ex312c70cb5.htm EX-31.2 18279
5 EX-32.1 amag-20150930ex3210b2876.htm EX-32.1 9086
6 EX-32.2 amag-20150930ex322bba0ec.htm EX-32.2 9212
  Complete submission text file 0001558370-15-002383.txt   11611133

Data Files

Seq Description Document Type Size
7 EX-101.INS amag-20150930.xml EX-101.INS 2821859
8 EX-101.SCH amag-20150930.xsd EX-101.SCH 68291
9 EX-101.CAL amag-20150930_cal.xml EX-101.CAL 105170
10 EX-101.DEF amag-20150930_def.xml EX-101.DEF 276703
11 EX-101.LAB amag-20150930_lab.xml EX-101.LAB 671257
12 EX-101.PRE amag-20150930_pre.xml EX-101.PRE 492151
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 151202479
SIC: 2834 Pharmaceutical Preparations